SulindacAn inhibitor of the NF-κB pathway and a Cox inhibitor

Sulindac (CAS 38194-50-2)

Sulindac | CAS 38194-50-2 is rated 5.0 out of 5 by 1.
  • y_2019, m_9, d_23, h_9
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.13
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202823, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 114ms
  • REVIEWS, PRODUCT
Synonym: MK-231; (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; cis-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]-indene-3-acetic acid
Application: An inhibitor of the NF-κB pathway and a Cox inhibitor
CAS Number: 38194-50-2
Purity: ≥98%
Molecular Weight: 356.41
Molecular Formula: C20H17FO3S
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Sulindac inhibits the NF-κB pathway. Sulindac is a non-steroidal anti-inflammatory drug. Sulindac reduces the level and activity of several cyclin-dependent kinases (CDKs) and induces apoptosis. Sulindac metabolizes to sulindac sulfide (sc-200118), a Cox (cyclooxygenase) inhibitor that represses ras signaling, and sulindac sulfone (sc-200120), an antitumor agent. Sulindac is an inhibitor of Cox-1 and Cox-2.


References

1. Shen, T.Y. and Winter, C.A. 1977. Adv. Drug Res. 12: 290- 245. PMID: 343530
2. Taylor, M.T., et al. 2000. Cancer Res. 60: 6607-6610. PMID: 11118042
3. Haanen, C. 2001. Curr. Opin. Invest. Drugs. 2: 677-683. PMID: 11569947

Physical State :
Solid
Solubility :
Soluble in water (0.05 mg/ml at 25° C), methanol (50 mg/ml), ethanol (9 mg/ml at 25° C), DMSO (71 mg/ml at 25° C), and DMF (~ 30 mg/ml).
Storage :
Store at room temperature
Melting Point :
183° C
Boiling Point :
581.64° C at 760 mmHg (Predicted)
Density :
~1.39 g/cm3 (Predicted)
Refractive Index :
n20D 1.67 (Predicted)
pK Values :
pKa: 4.7
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
NK8226000
PubChem CID :
1548885
Merck Index :
14: 8982
MDL Number :
MFCD00599589
EC Number :
253-819-2
Beilstein Registry :
2951842
SMILES :
CC\\1=C(C2=C(/C1=C/C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 64ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Haanen (PubMed ID 11569947) found that Sulindac Haanen (PubMed ID 11569947) found that Sulindac showed anticancer properties by inhibiting cyclic-GMP phosphodiesterase, increasing cGMP to activate protein kinase G and inducing transcription of caspase genes, resulting in apoptosis. -SCBT Publication Review
Date published: 2015-03-01
  • y_2019, m_9, d_23, h_9
  • bvseo_bulk, prod_bvrr, vn_bulk_2.0.13
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_202823, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.